REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 106 filers reported holding REPLIMUNE GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,136 | -32.9% | 4,216 | -9.0% | 0.04% | -31.2% |
| Q2 2023 | $107,532 | +68.1% | 4,631 | +27.8% | 0.06% | +82.9% |
| Q1 2023 | $63,982 | -53.1% | 3,623 | -27.8% | 0.04% | -50.7% |
| Q4 2022 | $136,517 | +10.1% | 5,019 | -29.8% | 0.07% | +44.9% |
| Q3 2022 | $124,000 | 0.0% | 7,153 | +0.6% | 0.05% | +6.5% |
| Q2 2022 | $124,000 | +29.2% | 7,108 | +25.9% | 0.05% | +7.0% |
| Q1 2022 | $96,000 | -40.7% | 5,647 | -5.7% | 0.04% | -29.5% |
| Q4 2021 | $162,000 | -11.0% | 5,986 | -2.4% | 0.06% | -23.8% |
| Q3 2021 | $182,000 | -26.6% | 6,134 | -4.9% | 0.08% | -21.6% |
| Q2 2021 | $248,000 | +18.1% | 6,452 | -6.3% | 0.10% | +14.6% |
| Q1 2021 | $210,000 | -18.6% | 6,887 | +1.7% | 0.09% | -16.8% |
| Q4 2020 | $258,000 | – | 6,769 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |